{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:55:37Z","timestamp":1785477337748,"version":"3.56.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"am","delay-in-days":325,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005235","name":"Institute for Advanced Study","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["291763"],"award-info":[{"award-number":["291763"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR179"],"award-info":[{"award-number":["TRR179"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["89004343"],"award-info":[{"award-number":["89004343"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["94-03-27-30456"],"award-info":[{"award-number":["94-03-27-30456"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005014","name":"Avicenna Research Institute","doi-asserted-by":"publisher","award":["AV\/FP109"],"award-info":[{"award-number":["AV\/FP109"]}],"id":[{"id":"10.13039\/501100005014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.antiviral.2017.06.013","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T15:03:08Z","timestamp":1497970988000},"page":"153-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg)"],"prefix":"10.1016","volume":"144","author":[{"given":"Forough","family":"Golsaz-Shirazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mehdi","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Farid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motahareh","family":"Bahadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Bohne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Altstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohid","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Khoshnoodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hojjat-Farsangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Jeddi-Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Protzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazel","family":"Shokri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.06.013_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jcv.2012.04.027","article-title":"HBsAg variants: diagnostic-escape and diagnostic dilemma","volume":"57","author":"Alavian","year":"2013","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2017.06.013_bib2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/trf.12096","article-title":"Infectivity of blood products from donors with occult hepatitis B virus infection","volume":"53","author":"Allain","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.antiviral.2017.06.013_bib3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/imt.13.67","article-title":"Construction and characterization of a new chimeric antibody against HER2","volume":"5","author":"Amiri","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.antiviral.2017.06.013_bib4","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/infdis\/jiw049","article-title":"Multiple hepatitis B virus (HBV) quasispecies and immune-escape mutations are present in HBV surface antigen and reverse transcriptase of patients with acute hepatitis B","volume":"213","author":"Aragri","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.06.013_bib5","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.3748\/wjg.v11.i48.7569","article-title":"High affinity mouse-human chimeric Fab against Hepatitis B surface antigen","volume":"11","author":"Bose","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2017.06.013_bib6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1440-1746.2006.04329.x","article-title":"Generation and characterization of a single-gene mouse-human chimeric antibody against hepatitis B surface antigen","volume":"21","author":"Bose","year":"2006","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2017.06.013_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0140-6736(90)91874-A","article-title":"Vaccine-induced escape mutant of hepatitis B virus","volume":"336","author":"Carman","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2017.06.013_bib8","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1586\/erv.11.151","article-title":"Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity","volume":"10","author":"Cassidy","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2017.06.013_bib9","doi-asserted-by":"crossref","first-page":"e0125704","DOI":"10.1371\/journal.pone.0125704","article-title":"A\u00a0human monoclonal antibody against hepatitis B surface antigen with potent neutralizing activity","volume":"10","author":"Cerino","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.06.013_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcv.2013.06.011","article-title":"Performance of hepatitis B surface antigen tests with the first WHO international hepatitis B virus genotype reference panel","volume":"58","author":"Chudy","year":"2013","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2017.06.013_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3201\/eid1202.050038","article-title":"Detecting hepatitis B surface antigen mutants","volume":"12","author":"Coleman","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.06.013_bib12","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/hep.510300508","article-title":"Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to g145r and other naturally occurring \u201ca\u201d loop escape mutations","volume":"30","author":"Cooreman","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2017.06.013_bib13","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.4254\/wjh.v7.i27.2729","article-title":"Clinical significance of hepatitis B surface antigen mutants","volume":"7","author":"Coppola","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.antiviral.2017.06.013_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/19420862.2015.989042","article-title":"The therapeutic monoclonal antibody market","volume":"7","author":"Ecker","year":"2015","journal-title":"MAbs"},{"key":"10.1016\/j.antiviral.2017.06.013_bib15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/jhep.2000.9632","article-title":"Preclinical evaluation of two human anti\u2013hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees","volume":"32","author":"Eren","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2017.06.013_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000282074","article-title":"Occult hepatitis B virus infection: detection and significance","volume":"28","author":"Gerlich","year":"2010","journal-title":"Dig. Dis."},{"key":"10.1016\/j.antiviral.2017.06.013_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2217\/imt.16.3","article-title":"Hepatitis B immunopathogenesis and immunotherapy","volume":"8","author":"Golsaz-Shirazi","year":"2016","journal-title":"Immunotherapy"},{"key":"10.1016\/j.antiviral.2017.06.013_bib18","first-page":"127","article-title":"Construction and expression of hepatitis B surface antigen escape variants within the \u201ca\u201d determinant by site directed mutagenesis","volume":"10","author":"Golsaz Shirazi","year":"2013","journal-title":"Iran. J. Immunol."},{"key":"10.1016\/j.antiviral.2017.06.013_bib19","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/jgh.12483","article-title":"Monoclonal antibodies to various epitopes of HBs antigen inhibit HBV infection","volume":"29","author":"Golsaz Shirazi","year":"2014","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2017.06.013_bib20","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0264-410X(99)00394-1","article-title":"The IgG subclass profile of anti-HBs response in vaccinated children and children seroconverted after natural infection","volume":"18","author":"Gregorek","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.06.013_bib21","first-page":"83","article-title":"Immunological properties of recombinant HBsAg produced in yeast","volume":"63","author":"Hauser","year":"1986","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.antiviral.2017.06.013_bib22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/BF02912459","article-title":"Distribution of IgG subclasses after anti-hepatitis B virus immunization with a recombinant vaccine","volume":"27","author":"Honorati","year":"1997","journal-title":"Int. J. Clin. Lab. Res."},{"key":"10.1016\/j.antiviral.2017.06.013_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7150\/ijms.2.50","article-title":"Epidemiology and prevention of hepatitis B virus infection","volume":"2","author":"Hou","year":"2005","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.antiviral.2017.06.013_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/hep.24363","article-title":"Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy","volume":"54","author":"Hsu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2017.06.013_bib25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.antiviral.2008.03.006","article-title":"Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees","volume":"79","author":"Kim","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.06.013_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0161-5890(90)90144-O","article-title":"Construction, expression and characterization of a murine\/human chimeric antibody with specificity for hepatitis B surface antigen","volume":"27","author":"Li","year":"1990","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.antiviral.2017.06.013_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jviromet.2005.03.018","article-title":"Production and characterization of recombinant human anti-HBs Fab antibodies","volume":"127","author":"Maeda","year":"2005","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.antiviral.2017.06.013_bib28","doi-asserted-by":"crossref","first-page":"e39028","DOI":"10.1371\/journal.pone.0039028","article-title":"Hepatitis B virus gene mutations in liver diseases: a report from New Delhi","volume":"7","author":"Malik","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2017.06.013_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"Naghavi","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2017.06.013_bib30","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3892\/ijo_32_6_1263","article-title":"Novel humanized anti-CD20 monoclonal antibodies with unique germline VH and VL gene recruitment and potent effector functions","volume":"32","author":"Nishida","year":"2008","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.antiviral.2017.06.013_bib31","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jhep.2014.11.028","article-title":"Intracellular accumulation of subviral HBsAg particles and diminished Nrf2 activation in HBV genotype G expressing cells lead to an increased ROI level","volume":"62","author":"Peiffer","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2017.06.013_bib32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/hep.510270138","article-title":"Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation","volume":"27","author":"Protzer-Knolle","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2017.06.013_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/hyb.2005.24.71","article-title":"Epitope mapping of recombinant hepatitis B surface antigen by murine monoclonal antibodies","volume":"24","author":"Roohi","year":"2005","journal-title":"Hybrid. (Larchmt)"},{"key":"10.1016\/j.antiviral.2017.06.013_bib34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/(SICI)1096-9071(199706)52:2<226::AID-JMV18>3.0.CO;2-I","article-title":"In\u00a0vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen","volume":"52","author":"Ryu","year":"1997","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2017.06.013_bib35","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2017.06.013_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.antiviral.2007.01.005","article-title":"Human monoclonal antibody against Hepatitis B virus surface antigen (HBsAg)","volume":"75","author":"Shin","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.06.013_bib37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s005350300043","article-title":"Molecular analysis of antigenicity and immunogenicity of a vaccine-induced escape mutant of hepatitis B virus","volume":"38","author":"Shizuma","year":"2003","journal-title":"J.\u00a0Gastroenterol."},{"key":"10.1016\/j.antiviral.2017.06.013_bib38","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/0264-410X(90)90221-7","article-title":"Development and production aspects of a recombinant yeast-derived hepatitis B vaccine","volume":"8","author":"Stephenne","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2017.06.013_bib39","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.28685","article-title":"Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection","volume":"64","author":"Thomsen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2017.06.013_bib40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0378-4347(98)00181-9","article-title":"Size-exclusion chromatographic study of the reduction of recombinant hepatitis B surface antigen","volume":"713","author":"Tleugabulova","year":"1998","journal-title":"J.\u00a0Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.antiviral.2017.06.013_bib41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0378-4347(98)00297-7","article-title":"Aggregation of recombinant hepatitis B surface antigen in Pichia pastoris","volume":"716","author":"Tleugabulova","year":"1998","journal-title":"J.\u00a0Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.antiviral.2017.06.013_bib42","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2017.06.013_bib43","series-title":"Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection","author":"WHO","year":"2015"},{"key":"10.1016\/j.antiviral.2017.06.013_bib44","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/gutjnl-2014-308964","article-title":"Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen","volume":"65","author":"Zhang","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2017.06.013_bib45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/cr.2007.13","article-title":"Antibody gene therapy: an attractive approach for the treatment of cancers and other chronic diseases","volume":"17","author":"Zheng","year":"2007","journal-title":"Cell Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216305447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216305447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:27:03Z","timestamp":1759062423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216305447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":45,"alternative-id":["S0166354216305447"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.06.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg)","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}